Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Title of publication:

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita

Authors:

Iwata H, Pipi E, Möckel N, Sondermann P, Vorobyev A, van Beek N, Zillikens D, Ludwig RJ

Year of Publication:

2014

medium resp. publishing house / place:

J Invest Dermatol.

edition / issue:

Mar 2015; Epub 20 / Oct 2014

Pages:

916-919

related to project:

Genotype-environment interactions for quantitative trait loci affecting common chronic inflammatory diseases

Pubmed: